An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease

Experimental Hematology

Volumn 32, Issue 3, 2004, Pages 318-324

  Welniak, Lisbeth A ^a   Wang, Zhao ^b   Sun, Kai ^b   Kuziel, William ^c   Anver, Miriam R ^b   Blazar, Bruce R ^d   Murphy, William J ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ACCELERATION; ALLOIMMUNITY; ANIMAL MODEL; ARTICLE; BONE ALLOGRAFT; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CONDITIONING; CONTROLLED STUDY; DONOR; GRAFT VERSUS HOST REACTION; HISTOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; SPLEEN CELL; T LYMPHOCYTE; WILD TYPE;

ACUTE DISEASE; ANIMALS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CHEMOKINES; DISEASE PROGRESSION; GRAFT VS HOST DISEASE; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RADIATION CHIMERA; RECEPTORS, CCR5; T-LYMPHOCYTE SUBSETS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

MURINAE;

EID: 1542357313     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2003.12.003     Document Type: Article

References (30)

1. Murphy W.J., Blazar B.R. New strategies for preventing graft-vs-host disease. Curr Opin Immunol. 11:1999;509-515.
2. Colby C., Sykes M., Sachs D., Spitzer T. Cellular modulation of acute graft-vs-host disease. Biol Blood Marrow Transplant. 3:1997;287-293.
3. Ferrara J., Cooke K., Pan L., Krenger W. The immunopathophysiology of acute graft-vs-host-disease. Stem Cells. 14:1996;473-489.
4. Sun K., Murphy W.J., Welniak L.A. In vivo models for the study of graft-vs-host disease and graft-vs-tumor effects. Laughlin M.J., Lazarus H.M. Allogeneic Stem Cell Transplantation: Clinical Research and Practice. 2003;373-386 Humana Press, Totowa, NJ.
5. Hill G., Crawford J., Cooke K., Brinson Y., Pan L., Ferrara J. Total body irradiation and acute graft-vs-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood. 90:1997;3204-3213.
6. Mackay C.R. Chemokines: immunology's high impact factors. Nat Immunol. 2:2001;95-101.
7. Kunkel E.J., Butcher E.C. Chemokines and the tissue-specific migration of lymphocytes. Immunity. 16:2002;1-4.
8. + T cells to the liver, lung, and spleen during graft-vs-host disease. Blood. 96:2000;2973-2980.
9. + T lymphocytes in the pathogenesis of liver injury in graft-vs-host disease. J Clin Invest. 104:1999;49-57.
10. Murai M., Yoneyama H., Ezaki T., et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-vs-host reaction. Nat Immunol. 4:2003;154-160.
11. Sato N., Kuziel W.A., Melby P.C., et al. Defects in the generation of IFN-γ are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein1α-, or CCR2-deficient mice. J. Immunol. 163:1999;5519-5525.
12. Ben-Ari Z., Hochhauser E., Burstein I., et al. Role of anti-tumor necrosis factor-α in ischemia/reperfusion injury in isolated rat liver in a blood-free environment. Transplantation. 73:2002;1875-1880.
13. DeVries M.E., Hosiawa K.A., Cameron C.M., et al. The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury. Semin Immunol. 15:2003;33-48.
14. Hixon J.A., Blazar B.R., Anver M.R., Wiltrout R.H., Murphy W.J. Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation. Biol Blood Marrow Transplant. 7:2001;136-143.
15. Wysocki C., Burkett S., Kirby S., et al. Absence of CCR5 on donor T cells accelerates GVHD. Blood. 100:2002;408b.
16. + T cells. J Immunol. 155:1995;2396-2406.
17. + T cell-mediated graft-vs-host disease: effects of conditioning. Biol Blood Marrow Transplant. 6:2000;604-612.
18. Murphy W.J., Welniak L.A., Taub D.D., et al. Differential effects of the absence of interferon-γ and IL-4 in acute graft-vs-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest. 102:1998;1742-1748.
19. Yang Y.G., Dey B.R., Sergio J.J., Pearson D.A., Sykes M. Donor-derived interferon γ is required for inhibition of acute graft-vs-host disease by interleukin 12. J Clin Invest. 102:1998;2126-2135.
20. + regulatory T cells plays a critical role in their ability to prevent GVHD. Blood. 102:2003;150a.
21. Nestel F., Price K., Seemayer T., Lapp W. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor α during graft-vs-host disease. J Exp Med. 175:1992;405-413.
22. Panoskaltsis-Mortari A., Hermanson J.R., Taras E., Wangensteen O.D., Serody J.S., Blazar B.R. Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 α (CCL3) after allogeneic BMT in mice. Blood. 101:2003;3714-3721.
23. Ng-Cashin J., Kuhns J.J., Burkett S.E., et al. Host absence of CCR5 potentiates dendritic cell vaccination. J Immunol. 170:2003;4201-4208.
24. Anders H.J., Frink M., Linde Y., et al. CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol. 170:2003;5658-5666.
25. Lillard J.W. Jr., Boyaka P.N., Taub D.D., McGhee J.R. RANTES potentiates antigen-specific mucosal immune responses. J Immunol. 166:2001;162-169.
26. Taub D., Ortaldo J., Turcovski-Corrales S., Key M., Longo D., Murphy W. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol. 59:1996;81-89.
27. Zhou Z., Kim Y.J., Pollok K., et al. Macrophage inflammatory protein-1α rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes. J Immunol. 151:1993;4333-4341.
28. Bystry R.S., Aluvihare V., Welch K.A., Kallikourdis M., Betz A.G. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol. 2:2001;1126-1132.
29. + regulatory T cells suppress lethal acute graft-vs-host disease after allogeneic bone marrow transplantation. J Exp Med. 196:2002;389-399.
30. + immune regulatory cells inhibits graft-vs-host disease lethality. Blood. 99:2002;3493-3499.